fda stops semaglutide compounding alerts health care providers, compounders and patients of dosing errors associated with compounded injectable products fda-approved compounding pharmacy semaglutide Compounded

doi: 10.1038/s12276-021-00670-3

Final Thoughts Getting GLP-1s online is now easier than ever, with telehealth platforms and pharmacies offering convenient access to weight loss medications

Without ongoing maintenance, even a well-built platform can face performance issues, security risks, and compliance challenges over time

PlexusDx compounded semaglutide injection at $149 per month costs $1,788 annuallya predictable amount with no hidden copays, coinsurance, or deductible requirements

This new drug, semaglutide, was first approved for diabetes in 2017 under the brand name Ozempic and then in 2021 for weight loss as Wegovy